A team of researchers has completed a comprehensive genomic analysis of cervical cancer in two patient populations and has identified recurrent genetic mutations not previously found in the disease including at least one for which targeted treatments have been approved for other forms of cancer. The study by researchers from the Boston area Mexico and Norway also shed light on the role human papillomavirus (HPV) plays in the development of cervical cancer. To investigate the genomic underpinnings of the disease the team performed whole exome sequencing which examines the genetic code in the protein-coding regions of the genome on samples